Phibro(US:PAHC) Businesswire·2025-10-30 17:00Core Insights - Phibro Animal Health Corporation has launched Restoris™ piezoelectric dental gel, aimed at improving oral health in dogs suffering from periodontal disease [1] - The product was developed in collaboration with a prominent U.S. dental school and is licensed to Phibro, indicating a strong foundation in veterinary dental care innovation [1] - Restoris™ employs a dual mechanism of action to restore oral health, marking a significant advancement in the veterinary dental care market [1] Company Overview - Phibro Animal Health Corporation is positioning itself as a leader in veterinary dental care with the introduction of Restoris™, highlighting its commitment to enhancing animal health [1] - The collaboration with a leading dental school underscores the company's focus on research and development in the veterinary sector [1] Industry Impact - The launch of Restoris™ is expected to address a critical need in the veterinary market for effective treatments for periodontal disease in dogs, potentially expanding the company's market share [1] - This innovation may set a new standard in veterinary dental care, influencing competitors and driving further advancements in the industry [1]